Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI
NCT01859338 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2018-03-07
Summary
This clinical trial studies magnetic resonance imaging (MRI), cone beam computed tomography (CT), and fan beam CT in detecting soft tissue in patients with prostate and lung cancer undergoing radiation therapy. Comparing results of diagnostic procedures done before and during radiation therapy may help doctors predict a patient's response to treatment and help plan the best treatment.
Conditions
Interventions
- RADIATION
-
cone-beam computed tomography
Undergo CBCT
- RADIATION
-
magnetic resonance imaging
Undergo MRI
- RADIATION
-
computed tomography
Undergo fan beam computed tomography
Sponsors & Collaborators
-
Virginia Commonwealth University
lead OTHER
Principal Investigators
-
Elisabeth Weiss, MD · Massey Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-06
- Primary Completion
- 2017-01-18
- Completion
- 2017-01-24
Countries
- United States
Study Locations
More Related Trials
-
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
NCT05543954 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
NCT05524454 ·Status: COMPLETED ·Phase: NA
-
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
NCT04809584 ·Status: APPROVED_FOR_MARKETING
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
NCT00310219 ·Status: COMPLETED ·Phase: NA
-
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
NCT03613259 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant
NCT03418090 ·Status: COMPLETED ·Phase: PHASE3
-
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
NCT01610544 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Comparison of 18F FDG PET/CT TO PET MRI
NCT01986985 ·Status: COMPLETED ·Phase: NA
-
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00847509 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814 ·Status: RECRUITING
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
NCT04147494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
NCT02397408 ·Status: COMPLETED ·Phase: PHASE2
-
Advanced Imaging for Pulmonary Fibrosis
NCT06532071 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
NCT01825902 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
NCT01180907 ·Status: COMPLETED
-
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
NCT04367948 ·Status: UNKNOWN ·Phase: NA
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection
NCT03417687 ·Status: COMPLETED ·Phase: PHASE3